Top

Published in:

01-02-2013 | Research Paper

Expression of HOXD3 correlates with shorter survival in patients with invasive breast cancer

Authors: Cheng Shaoqiang, Zhang Yue, Liu Yang, Zhao Hong, Zhen Lina, Pang Da, Zhang Qingyuan

Published in: Clinical & Experimental Metastasis | Issue 2/2013

Abstract

Hox genes encode a family of homeodomain-containing transcription factors that determine cellular identity during development and which are also expressed in some types of cancer. The HOXD3 gene, a member of the Hox gene family, has been demonstrated to be expressed in several tumor cell lines, which exhibit enhanced invasion and metastasis through coordinate expression of metastasis-associated factors. However, the clinical impact of HOXD3 in breast cancer remains unclear. In the current study, we examined the expression of HOXD3 and integrin β3 by immunohistochemical staining in patients with invasive breast cancer. We found that HOXD3 expression was significantly frequent in high histopathological grade and hormone-receptor negative breast cancer patients. The expression of HOXD3 was closely associated with integrin β3 expression. Furthermore, patients with high HOXD3 expression levels in their breast tumors had significantly shorter survival times than patients in which HOXD3 was weakly expressed in breast tumors. Univariate and multivariate analyses confirmed that increased HOXD3-expression was an independent and significant factor in predicting poor prognosis for patients with breast cancer. In conclusion, HOXD3 expression is a significant unfavorable prognostic factor for patients with invasive breast cancer and as such is a potentially useful prognostic marker for breast cancer.

Gehring WJ, Hiromi Y (1986) Homeotic genes and the homeobox. Annu Rev Genet 20:147–173PubMedCrossRef

Scott MP (1992) Vertebrate homeobox gene nomenclature. Cell 71:551–553PubMedCrossRef

Graham A, Papalopulu N, Krumlauf R (1989) The murine and Drosophila homeobox gene complexes have common features of organization and expression. Cell 57:367–378PubMedCrossRef

McGinnis W, Krumlauf R (1992) Homeobox genes and axial patterning. Cell 68:283–302PubMedCrossRef

Levine M, Hoey T (1988) Homeobox proteins as sequence-specific transcription factors. Cell 55:537–540PubMedCrossRef

Ruddle FH et al (1994) Evolution of Hox genes. Annu Rev Genet 28:423–442PubMedCrossRef

Mark M, Rijli FM, Chambon P (1997) Homeobox genes in embryogenesis and pathogenesis. Pediatr Res 42:421–429PubMedCrossRef

Takahashi Y et al (2004) Expression profiles of 39 HOX genes in normal human adult organs and anaplastic thyroid cancer cell lines by quantitative real-time RT-PCR system. Exp Cell Res 293:144–153PubMedCrossRef

Abate-Shen C (2002) Deregulated homeobox gene expression in cancer: cause or consequence? Nat Rev Cancer 2:777–785PubMedCrossRef

10.

Raman V et al (2000) Compromised HOXA5 function can limit p53 expression in human breast tumours. Nature 405:974–978PubMedCrossRef

11.

Trivedi CM, Patel RC, Patel CV (2007) Homeobox gene HOXA9 inhibits nuclear factor-kappa B dependent activation of endothelium. Atherosclerosis 195:e50–e60PubMedCrossRef

12.

Trivedi CM, Patel RC, Patel CV (2008) Differential regulation of HOXA9 expression by nuclear factor kappa B (NF-kappaB) and HOXA9. Gene 408:187–195PubMedCrossRef

13.

Wu X et al (2006) HOXB7, a homeodomain protein, is overexpressed in breast cancer and confers epithelial–mesenchymal transition. Cancer Res 66:9527–9534PubMedCrossRef

14.

Condie BG, Capecchi MR (1993) Mice homozygous for a targeted disruption of Hoxd-3 (Hox-4.1) exhibit anterior transformations of the first and second cervical vertebrae, the atlas and the axis. Development 119:579–595PubMed

15.

Manley NR, Capecchi MR (1998) Hox group 3 paralogs regulate the development and migration of the thymus, thyroid, and parathyroid glands. Dev Biol 195:1–15PubMedCrossRef

16.

Hamada J et al (2001) Overexpression of homeobox gene HOXD3 induces coordinate expression of metastasis-related genes in human lung cancer cells. Int J Cancer 93:516–525CrossRef

17.

Taniguchi Y, Komatsu N, Moriuchi T (1995) Overexpression of the HOX4A (HOXD3) homeobox gene in human erythroleukemia HEL cells results in altered adhesive properties. Blood 85:2786–2794PubMed

18.

Haybittle JL et al (1982) A prognostic index in primary breast cancer. Br J Cancer 45:361–366PubMedCrossRef

19.

Kowalski PJ, Rubin MA, Kleer CG (2003) E-cadherin expression in primary carcinomas of the breast and its distant metastases. Breast Cancer Res 5:R217–R222PubMedCrossRef

20.

Huber GF et al (2011) Down regulation of E-cadherin (ECAD)—a predictor for occult metastatic disease in sentinel node biopsy of early squamous cell carcinomas of the oral cavity and oropharynx. BMC cancer 11(217):1–8PubMed

21.

Kashiwagi S et al (2010) Significance of E-cadherin expression in triple-negative breast cancer. Br J Cancer 103:249–255PubMedCrossRef

22.

Frixen UH et al (1991) E-cadherin-mediated cell–cell adhesion prevents invasiveness of human carcinoma cells. J Cell Biol 113:173–185PubMedCrossRef

23.

Vleminckx K et al (1991) Genetic manipulation of E-cadherin expression by epithelial tumor cells reveals an invasion suppressor role. Cell 66:107–119PubMedCrossRef

24.

Watabe M et al (1994) Induction of polarized cell–cell association and retardation of growth by activation of the E-cadherin-catenin adhesion system in a dispersed carcinoma line. J Cell Biol 127:247–256PubMedCrossRef

25.

Mariotti A et al (2007) N-cadherin as a therapeutic target in cancer. Expert Opin Investig Drugs 16:451–465PubMedCrossRef

26.

Cavallaro U (2004) N-cadherin as an invasion promoter: a novel target for antitumor therapy? Curr Opin Investig Drugs 5:1274–1278PubMed

27.

Hazan RB et al (2000) Exogenous expression of N-cadherin in breast cancer cells induces cell migration, invasion, and metastasis. J Cell Biol 148:779–790PubMedCrossRef

28.

Planaguma J et al (2011) Matrix metalloproteinase-2 and matrix metalloproteinase-9 codistribute with transcription factors RUNX1/AML1 and ETV5/ERM at the invasive front of endometrial and ovarian carcinoma. Hum Pathol 42:57–67PubMedCrossRef

29.

Shen Q et al (2010) Tissue inhibitor of metalloproteinase-2 regulates matrix metalloproteinase-2-mediated endothelial barrier dysfunction and breast cancer cell transmigration through lung microvascular endothelial cells. Mol Cancer Res 8:939–951PubMed

30.

Takayama S et al (2005) The relationship between bone metastasis from human breast cancer and integrin alpha(v)beta3 expression. Anticancer Res 25:79–83PubMed

31.

Scatena M et al (1998) NF-kappaB mediates alphavbeta3 integrin-induced endothelial cell survival. J Cell Biol 141:1083–1093PubMedCrossRef

32.

Matter ML, Ruoslahti E (2001) A signaling pathway from the alpha5beta1 and alpha(v)beta3 integrins that elevates bcl-2 transcription. J Biol Chem 276:27757–27763PubMedCrossRef

33.

De S et al (2005) VEGF-integrin interplay controls tumor growth and vascularization. Proc Natl Acad Sci USA 102:7589–7594PubMedCrossRef

Title: Expression of HOXD3 correlates with shorter survival in patients with invasive breast cancer
Authors: Cheng Shaoqiang
Zhang Yue
Liu Yang
Zhao Hong
Zhen Lina
Pang Da
Zhang Qingyuan
Publication date: 01-02-2013
Publisher: Springer Netherlands
Published in: Clinical & Experimental Metastasis / Issue 2/2013
Print ISSN: 0262-0898
Electronic ISSN: 1573-7276
DOI: https://doi.org/10.1007/s10585-012-9524-y

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras

Prof. Fabrice Barlesi

Developed by: Springer Medicine

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 2/2013

The clinicopathological evaluation of the breast cancer patients with brain metastases: predictors of survival

Transcriptional profiling identifies genes induced by hepatocyte-derived extracellular matrix in metastatic human colorectal cancer cell lines

Rapamycin inhibits both motility through down-regulation of p-STAT3 (S727) by disrupting the mTORC2 assembly and peritoneal dissemination in sarcomatoid cholangiocarcinoma

A micro-imaging study linking bone cancer pain with tumor growth and bone resorption in a rat model

Attenuation of reactive oxygen species by antioxidants suppresses hypoxia-induced epithelial-mesenchymal transition and metastasis of pancreatic cancer cells

Inhibition of metastatic tumor formation in vivo by a bacteriophage display-derived galectin-3 targeting peptide

Keynote webinar | Spotlight on antibody–drug conjugates in cancer